NCT06233097View on ClinicalTrials.gov

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 29, 2024

Primary Completion Date

September 28, 2024

Study Completion Date

October 12, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Esomeprazole magnesium dihydrate-Test product

Esomeprazole magnesium dihydrate 40 mg tablets Manufactured by: Cipla Limited, India

DRUG

Esomeprazole magnesium dihydrate-Reference product

Esomeprazole magnesium dihydrate 40 mg tablets Manufactured by: AstraZeneca AB, Kingdom of Sweden

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY

NCT06233097 - Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition | Biotech Hunter | Biotech Hunter